▲ Peaking
Business
Vera kidney drug Trutakna shows strong final results in Phase 3 trial
Vera Therapeutics reports strong final Phase 3 trial data for its kidney drug Trutakna, sharpening competition with Vertex.
Iga Nephropathy
1 trends tracked about this subject — the full history, oldest to newest below.